Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine
New England Journal of Medicine · 30.03.2023 · 388 (13) · 1233-1239
DOI: 10.1056/nejmsr2214184 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, erschienen am 30.03.2023. Verfasst von Peter Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: From Microsoft Research, Redmond, WA (P.L., S.B.); and Nuance Communications, Burlington, MA (J.P.). Hauptthemen laut MEDLINE: Artificial Intelligence, Medicine. Die Arbeit wurde bisher 1779-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Chatbots are computer programs with which one can have a conversation. In this article, the authors describe how the GPT-4 chatbot, which has been given a general education, could affect the practice of medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- From Microsoft Research, Redmond, WA (P.L., S.B.); and Nuance Communications, Burlington, MA (J.P.).
ORCID-Profile: Peter Lee
Zitieren
APA
Lee, P., Bubeck, S., & Petro, J. (2023). Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine. New England Journal of Medicine, 388(13), 1233-1239. https://doi.org/10.1056/nejmsr2214184
Vancouver
Lee P, Bubeck S, Petro J. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine. New England Journal of Medicine. 2023;388(13):1233-1239. doi:10.1056/nejmsr2214184
BibTeX
@article{Lee2023,
author = {Lee, Peter and Bubeck, Sebastien and Petro, Joseph},
title = {Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine},
journal = {New England Journal of Medicine},
year = {2023},
volume = {388},
number = {13},
pages = {1233--1239},
doi = {10.1056/nejmsr2214184}
}
EUVIMED